ACIU

AC Immune S.A.

Price

$2.64

return (12m)

7.76%

p/e

-3.54

p/bv

7.46

DIVIDEND YIELD

0.00%

ACIU price

AC Immune

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ACIU

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.98%

3 months

10.00%

1 year

7.76%

2 years

-28.46%

5 years

-61.15%

10 years

-83.14%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ACIU

Valuation

P/E

-3.54

Sector -3.50

Industry -3.50

P/BV

7.46

Sector 2.02

Industry 2.02

P/Revenue (PSR)

13.40

Sector 2.01

Industry 2.01

EV/EBITDA

96.72

Sector -214.99

Industry -214.99

EV/EBIT

96.72

Sector -47.59

Industry -47.59

P/EBITDA

-6.25

Sector -21.41

Industry -21.41

P/EBIT

-6.07

Sector -28.65

Industry -28.65

P/Total Assets

1.75

Sector 1.19

Industry 1.19

P/Net Current Assets

-12.02

Sector -11.97

Industry -11.97

P/Working Capital

-38.39

Sector -167.95

Industry -167.95

EPS

-0.75

Sector -1.81

Industry -1.81

BVPS

0.35

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

100.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

11.92%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

11.92%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.11

Sector 0.02

Industry 0.02

Profitability

ROE

-210.97%

Sector -56.04%

Industry -56.04%

ROA

-49.33%

Sector -60.31%

Industry -60.31%

ROIC

3.26%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.93

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-38.94

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

-38.94

Sector -8.06

Industry -8.06

Net Debt / Equity

-2.14

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.23

Sector 0.46

Industry 0.46

Liabilities/Assets

0.77

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

3.18%

Sector -

Industry -

Fundamentals ACIU

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ACIU AC Immune S.A.	$2.64	7.32%	0.00%	-3.54	7.46	-210.97%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.32%	10.50	5.58	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.09%	2.33%	112.32	8.48	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	42.33%	3.96%	13.95	5.80	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.89%	11.41	9.59	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.62	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.37%	19.68	-26.99	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.63	6.45	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.88%	0.88%	31.71	-20.07	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ACIU Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT AC Immune

AC Immune S.A.

Average Investor10 user rating

4.0 (3 people)

United States

23 years

Founded: 2003

2016

Time since IPO - 10 years

123

Employees

AC Immune S.A. (United States) is listed on the Nasdaq and has a market capitalization of $328.43 million, with shareholders equity totaling $44.00 million.

The company employs approximately 123 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, AC Immune S.A. reported $24.51 million in revenue, generating net income of $-92.83 million.

Key financial metrics include a P/E ratio of -3.54, a price-to-book (P/B) ratio of 7.46, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ACIU.

Market cap

$328.43 million

Net worth

$44.00 million

$44,000,000.00

Assets

$188.17 million

$188,166,000.00

Total Shares Outstanding

124.41 million

124,406,000

Average Daily Trading Volume

$192.02 Thousand

$192,017.16

Sector

Health Care

Industry

Biotechnology

ACIU

ACIU revenue and profits

Financial Results ACIU

DRAG THE FRAME TO SEE MORE DATA

ACIU cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,90% (12M)

P/E

19.68

0.37%

ROE

-137.16%

P/BV

-26.99

CAH - Cardinal Health

$224.45 51,94% (12M)

P/E

31.71

0.88%

ROE

-63.29%

P/BV

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 86,25% (12M)

P/E

112.32

2.33%

ROE

7.55%

P/BV

8.48

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,90% (12 M)

P/L

19.68

0.37%

ROE

-137.16%

P/VP

-26.99

CAH - Cardinal Health

$224.45 51,94% (12 M)

P/L

31.71

0.88%

ROE

-63.29%

P/VP

-20.07

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 86,25% (12 M)

P/L

112.32

2.33%

ROE

7.55%

P/VP

8.48

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of AC Immune (ACIU) today?

A cotação de AC Immune (ACIU) hoje está em US$ 2.64, com uma variação de 7.76% em relação ao último ano. A cotação de AC Immune (ACIU) iniciou o ano negociando na casa dos US$ 3.14 e hoje está em US$ 2.64. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de AC Immune (ACIU) e dados de ações do Ibovespa e mercados internacionais.

Quando AC Immune (ACIU) paga dividendos?

AC Immune (ACIU) não distribuiu dividendos no último ano.

Is AC Immune (ACIU) a good investment?

Atualmente, AC Immune (ACIU) está cotada a US$ 2.64, com um P/L de -3.54, representando um desvio de -332% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 7.76 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 7.76%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy AC Immune (ACIU) stock?

Investir em ações de AC Immune (ACIU) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of AC Immune (ACIU) yield today?

A rentabilidade de AC Immune (ACIU) foi de -7.98% no último mês, 7.76% no último ano e -61.15% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de AC Immune (ACIU) hoje, o investimento total seria de US$ 264.00, com base na cotação atual de US$ 2.64.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 284.49
Em 5 anos: US$ 102.56
Em 10 anos: US$ 44.51

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ACIU

AC Immune S.A.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ACIU

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ACIU WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT AC Immune

AC Immune S.A.

United States

23 years

2016

123

PROFIT X PRICE ACIU

Financial Results ACIU

ACIU cash flow

Asset, Revenue and Profit Growth - ACIU

ACIU balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions